首页> 外文期刊>Acta Radiologica >Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1–T2N0 breast cancer
【24h】

Association between US features of primary tumor and axillary lymph node metastasis in patients with clinical T1–T2N0 breast cancer

机译:患有临床T1-T2N0乳腺癌患者原发性肿瘤和腋窝淋巴结转移的联合关联

获取原文
获取原文并翻译 | 示例
       

摘要

Background Most patients with early-stage breast cancer have clinically negative lymph nodes (LNs). However, 15–20% of patients have axillary nodal metastasis based on the sentinel LN biopsy. Purpose To assess whether ultrasound (US) features of a primary tumor are associated with axillary LN metastasis in patients with clinical T1–T2N0 breast cancer. Material and Methods This retrospective study included 138 consecutive patients (median age?=?51 years; age range?=?27–78 years) who underwent breast surgery with axillary LN evaluation for clinically node-negative T1–T2 breast cancer. Three radiologists blinded to the axillary surgery results independently reviewed the US images. Tumor distance from the skin and distance from the nipple were determined based on the US report. Association between US features of a breast tumor and axillary LN metastasis was assessed using a multivariate logistic regression model after controlling for clinicopathologic variables. Results Of the 138 patients, 28 (20.3%) had nodal metastasis. At univariate analysis, tumor distance from the skin ( P ?=?0.019), tumor size on US ( P ?=?0.023), calcifications ( P ?=?0.036), architectural distortion ( P ?=?0.001), and lymphovascular invasion ( P ?=?0.049) were associated with axillary LN metastasis. At multivariate analysis, shorter skin-to-tumor distance (odds ratio [OR]?=?4.15; 95% confidence interval [CI]?=?1.01–16.19; P ?=?0.040) and masses with associated architectural distortion (OR?=?3.80; 95% CI?=?1.57–9.19; P ?=?0.003) were independent predictors of axillary LN metastasis. Conclusion US features of breast cancer can be promising factors associated with axillary LN metastasis in patients with clinically node-negative early-stage breast cancer.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号